DK175715B1 - Vaccine til beskyttelse af katte mod infektiös katteperitonitis - Google Patents

Vaccine til beskyttelse af katte mod infektiös katteperitonitis Download PDF

Info

Publication number
DK175715B1
DK175715B1 DK198805406A DK540688A DK175715B1 DK 175715 B1 DK175715 B1 DK 175715B1 DK 198805406 A DK198805406 A DK 198805406A DK 540688 A DK540688 A DK 540688A DK 175715 B1 DK175715 B1 DK 175715B1
Authority
DK
Denmark
Prior art keywords
virus
fip
vaccine
fip virus
cats
Prior art date
Application number
DK198805406A
Other languages
Danish (da)
English (en)
Other versions
DK540688A (da
DK540688D0 (da
Inventor
Jay Dean Gerber
Jerald Dee Ingersoll
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK540688D0 publication Critical patent/DK540688D0/da
Publication of DK540688A publication Critical patent/DK540688A/da
Application granted granted Critical
Publication of DK175715B1 publication Critical patent/DK175715B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK198805406A 1987-10-01 1988-09-28 Vaccine til beskyttelse af katte mod infektiös katteperitonitis DK175715B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10314487A 1987-10-01 1987-10-01
US10314487 1987-10-01

Publications (3)

Publication Number Publication Date
DK540688D0 DK540688D0 (da) 1988-09-28
DK540688A DK540688A (da) 1989-04-02
DK175715B1 true DK175715B1 (da) 2005-01-31

Family

ID=22293621

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198805406A DK175715B1 (da) 1987-10-01 1988-09-28 Vaccine til beskyttelse af katte mod infektiös katteperitonitis

Country Status (16)

Country Link
EP (1) EP0310362B1 (de)
JP (1) JP2608935B2 (de)
KR (1) KR890006255A (de)
AT (1) ATE103496T1 (de)
AU (1) AU620819B2 (de)
CA (1) CA1337116C (de)
DE (1) DE3888775T2 (de)
DK (1) DK175715B1 (de)
ES (1) ES2063048T3 (de)
FI (1) FI94488C (de)
HU (1) HU205264B (de)
IL (1) IL87911A0 (de)
NO (1) NO177555C (de)
NZ (1) NZ226353A (de)
PT (1) PT88592B (de)
ZA (1) ZA887263B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667785A (en) * 1987-10-01 1997-09-16 Pfizer Inc. Vaccine for protection of cats against feline infectious peritonitis
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
WO1993015762A1 (en) * 1992-02-18 1993-08-19 Parhelion Corporation Feline infectious peritonitis vaccine and method of preparation
US5670156A (en) * 1993-02-18 1997-09-23 Parhelion Corporation Feline infectious peritonitis vaccine and method of preparation
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US6033845A (en) * 1996-12-18 2000-03-07 Engene Biotechnologies Inc Specific diagnostic for feline infectious peritonitis antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195130A (en) * 1978-04-20 1980-03-25 Cornell Research Foundation, Inc. Propagation of feline infectious peritonitis virus in tissue cultures
DK507079A (da) * 1978-11-30 1980-05-31 Wellcome Found Svaekket stamme af infektioes katteperitonitisvirus,fremgangsmaade til dens fremstilling og vaccine indeholdende den svaekkedevirusstamme
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
WO1987004624A1 (en) * 1986-02-06 1987-08-13 Schering Corporation Feline infectious peritonitis vaccine

Also Published As

Publication number Publication date
NO177555C (no) 1995-10-11
EP0310362A2 (de) 1989-04-05
EP0310362B1 (de) 1994-03-30
PT88592B (pt) 1993-03-31
NO884340L (no) 1989-04-03
JPH01113321A (ja) 1989-05-02
DK540688A (da) 1989-04-02
PT88592A (pt) 1988-10-01
AU2293188A (en) 1989-04-06
EP0310362A3 (en) 1990-03-21
ZA887263B (en) 1989-09-27
JP2608935B2 (ja) 1997-05-14
AU620819B2 (en) 1992-02-27
FI884521A0 (fi) 1988-09-30
DK540688D0 (da) 1988-09-28
IL87911A0 (en) 1989-03-31
NO884340D0 (no) 1988-09-30
NO177555B (no) 1995-07-03
CA1337116C (en) 1995-09-26
HU205264B (en) 1992-04-28
ATE103496T1 (de) 1994-04-15
FI94488C (fi) 1995-09-25
NZ226353A (en) 1991-07-26
FI884521A (fi) 1989-04-02
DE3888775T2 (de) 1994-07-14
KR890006255A (ko) 1989-06-12
HUT47867A (en) 1989-04-28
DE3888775D1 (de) 1994-05-05
ES2063048T3 (es) 1995-01-01
FI94488B (fi) 1995-06-15

Similar Documents

Publication Publication Date Title
US11524068B2 (en) Methods of vaccine administration
EP0344872B2 (de) Impfstoff-Zubereitung
Brooksby Portraits of viruses: foot-and-mouth disease virus
Mumford et al. Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8)
Nicholas et al. Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses
Stoddart et al. Attempted immunisation of cats against feline infectious peritonitis using canine coronavirus
DK175715B1 (da) Vaccine til beskyttelse af katte mod infektiös katteperitonitis
ES2270508T3 (es) Coronavirus enterico y respiratorio bovino como vacuna.
Bingham et al. Innocuity studies of SAG-2 oral rabies vaccine in various Zimbabwean wild non-target species
Legendre et al. Efficacy of a feline leukemia virus vaccine in a natural exposure challenge
WO1993015762A1 (en) Feline infectious peritonitis vaccine and method of preparation
Masoudi et al. Immunogenicity and efficacy of live infectious bronchitis 793/B. 08IR vaccine in SPF chickens
Cox et al. Sites of replication of a porcine respiratory coronavirus in 5-week-old pigs with or without maternal antibodies
Fathy et al. Evaluation of bivalent inactivated infectious bronchitis viral vaccine prepared from local isolates
US5667785A (en) Vaccine for protection of cats against feline infectious peritonitis
EP1578374B1 (de) Escape-mutanten des newcastle-disease-virus als marker-vakzine
US5670156A (en) Feline infectious peritonitis vaccine and method of preparation
JP2023506304A (ja) 経口呼吸器ワクチン
Bashir Maternal immunity to Newcastle disease in egg yolk of layers
Kapczynski Development of a DNA vaccine against infectious bronchitis using the S1 gene from Arkansas serotype of infectious bronchitis virus: Protective immunity against infectious bronchitis virus following intramuscular or in ovo DNA vaccination
Allen Evaluation of transmissible gastroenteritis and porcine respiratory coronavirus immunologic interaction in seronegative pregnant gilts

Legal Events

Date Code Title Description
PUP Patent expired